The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/27972 |
Resumo: | The aim of this study is to summarize the evidence in the literature about the effect of probiotics on glycemic control in patients with type 2 diabetes mellitus (T2DM). This is an integrative literature review to answer the question: “What is the evidence on the use of probiotics to reduce fasting glucose and/or glycated hemoglobin and/or insulin resistance in people with T2DM”. The search was performed in the Medline-PubMed, Cochrane Library and Bireme databases using descriptors combined using the OR and AND operators. Randomized clinical trials performed with adult humans diagnosed with T2DM and which evaluated at least one of the outcomes of interest were included. The search resulted in 207 articles, of which 14 were included. The duration of the intervention ranged from 6 weeks to 6 months, the number of strains from 1 to 14, the daily dose from 106 to 1010 CFU. Most studies included Lactobacillus and Bifidobacterium. The species and strains that appeared the most were Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium lactis and Streptococcus Thermophilus. It is suggested that the use of probiotics may be a strategy for managing T2DM, as most studies have shown a positive effect on at least one of the parameters. |
id |
UNIFEI_e051d8b0f713fd670bfb189a69210e6d |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/27972 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature reviewEl efecto del uso de probióticos sobre la glucemia en ayunas, la resistencia a la insulina y la hemoglobina glicada en personas con Diabetes mellitus tipo 2: una revisión de la literaturaO efeito do uso de probióticos sobre glicemia de jejum, resistência à insulina e hemoglobina glicada em pessoas com Diabetes mellitus tipo 2: uma revisão de literaturaProbióticosDiabetes Mellitus Tipo 2Glucosa en sangreResistencia a la insulinaHemoglobina glicosilada.ProbióticosDiabetes Mellitus Tipo 2GlicemiaResistência à insulinaHemoglobina glicada.ProbioticsType 2 Diabetes MellitusBlood glucoseInsulin resistanceGlycated hemoglobin A. The aim of this study is to summarize the evidence in the literature about the effect of probiotics on glycemic control in patients with type 2 diabetes mellitus (T2DM). This is an integrative literature review to answer the question: “What is the evidence on the use of probiotics to reduce fasting glucose and/or glycated hemoglobin and/or insulin resistance in people with T2DM”. The search was performed in the Medline-PubMed, Cochrane Library and Bireme databases using descriptors combined using the OR and AND operators. Randomized clinical trials performed with adult humans diagnosed with T2DM and which evaluated at least one of the outcomes of interest were included. The search resulted in 207 articles, of which 14 were included. The duration of the intervention ranged from 6 weeks to 6 months, the number of strains from 1 to 14, the daily dose from 106 to 1010 CFU. Most studies included Lactobacillus and Bifidobacterium. The species and strains that appeared the most were Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium lactis and Streptococcus Thermophilus. It is suggested that the use of probiotics may be a strategy for managing T2DM, as most studies have shown a positive effect on at least one of the parameters.El objetivo de este estudio es resumir la evidencia en la literatura sobre el efecto de los probióticos en el control glucémico en pacientes con DM2. Esta es una revisión integrativa de la literatura para responder a la pregunta: “¿Cuál es la evidencia sobre el uso de probióticos para reducir la glucosa en ayunas y/o la hemoglobina glicosilada y/o la resistencia a la insulina en personas con DM2”. La búsqueda se realizó en las bases de datos Medline-PubMed, Cochrane Library y Bireme utilizando descriptores combinados mediante los operadores OR y AND. Se incluyeron ensayos clínicos aleatorizados realizados con humanos adultos diagnosticados de DM2 y que evaluaran al menos uno de los desenlaces de interés. La búsqueda resultó en 207 artículos, de los cuales se incluyeron 14. La duración de la intervención varió de 6 semanas a 6 meses, el número de cepas de 1 a 14, la dosis diaria de 106 a 1010 UFC. La mayoría de los estudios incluyeron Lactobacillus y Bifidobacterium. Las especies y cepas que más aparecieron fueron Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium lactis y Streptococcus Thermophilus. Se sugiere que el uso de probióticos puede ser una estrategia para el manejo de la DM2, ya que la mayoría de los estudios han demostrado un efecto positivo en al menos uno de los parámetros.O objetivo desse estudo é sumarizar as evidências da literatura acerca do efeito dos probióticos sobre o controle glicêmico em pacientes com diabetes mellitus tipo 2. Trata-se de uma revisão integrativa da literatura para responder à pergunta: “Quais as evidências sobre o uso de probióticos na redução de glicemia de jejum e/ou hemoglobina glicada e/ou resistência à insulina em pessoas com DM2”. A busca foi realizada nas bases de dados Medline-PubMed, Cochrane Library e Bireme por meio de descritores combinados a partir dos operadores OR e AND. Incluiu-se ensaios clínicos randomizados realizados com humanos adultos com diagnóstico de DM2 e que avaliaram pelo menos um dos desfechos de interesse. A busca resultou em 207 artigos, dos quais 14 foram incluídos. A duração da intervenção variou de 6 semanas a 6 meses, o número de cepas de 1 a 14, a dose de diária de 106 a 1010 UFC. A maioria dos estudos incluiu Lactobacillus e Bifidobacterium. As espécies e cepas que mais apareceram foram Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium lactis e Streptococcus Thermophilus. Sugere-se que o uso de probióticos possa ser uma estratégia para manejo do DM2, pois a maioria dos estudos revelou efeito positivo sobre pelo menos um dos parâmetros.Research, Society and Development2022-03-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2797210.33448/rsd-v11i5.27972Research, Society and Development; Vol. 11 No. 5; e10411527972Research, Society and Development; Vol. 11 Núm. 5; e10411527972Research, Society and Development; v. 11 n. 5; e104115279722525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/27972/24369Copyright (c) 2022 Mariana Pimentel Gomes Souza; Renata Cristina Machado Mendes; Dayanna Magalhães dos Reis; Maria Yasmin Paz Teixeira Martinshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSouza, Mariana Pimentel GomesMendes, Renata Cristina Machado Reis, Dayanna Magalhães dosMartins, Maria Yasmin Paz Teixeira2022-04-17T18:18:56Zoai:ojs.pkp.sfu.ca:article/27972Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:45:32.291489Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review El efecto del uso de probióticos sobre la glucemia en ayunas, la resistencia a la insulina y la hemoglobina glicada en personas con Diabetes mellitus tipo 2: una revisión de la literatura O efeito do uso de probióticos sobre glicemia de jejum, resistência à insulina e hemoglobina glicada em pessoas com Diabetes mellitus tipo 2: uma revisão de literatura |
title |
The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review |
spellingShingle |
The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review Souza, Mariana Pimentel Gomes Probióticos Diabetes Mellitus Tipo 2 Glucosa en sangre Resistencia a la insulina Hemoglobina glicosilada. Probióticos Diabetes Mellitus Tipo 2 Glicemia Resistência à insulina Hemoglobina glicada. Probiotics Type 2 Diabetes Mellitus Blood glucose Insulin resistance Glycated hemoglobin A. |
title_short |
The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review |
title_full |
The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review |
title_fullStr |
The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review |
title_full_unstemmed |
The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review |
title_sort |
The effect of probiotic use on fasting glycemia, insulin resistance and glycated hemoglobin in people with type 2 Diabetes mellitus: a literature review |
author |
Souza, Mariana Pimentel Gomes |
author_facet |
Souza, Mariana Pimentel Gomes Mendes, Renata Cristina Machado Reis, Dayanna Magalhães dos Martins, Maria Yasmin Paz Teixeira |
author_role |
author |
author2 |
Mendes, Renata Cristina Machado Reis, Dayanna Magalhães dos Martins, Maria Yasmin Paz Teixeira |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Souza, Mariana Pimentel Gomes Mendes, Renata Cristina Machado Reis, Dayanna Magalhães dos Martins, Maria Yasmin Paz Teixeira |
dc.subject.por.fl_str_mv |
Probióticos Diabetes Mellitus Tipo 2 Glucosa en sangre Resistencia a la insulina Hemoglobina glicosilada. Probióticos Diabetes Mellitus Tipo 2 Glicemia Resistência à insulina Hemoglobina glicada. Probiotics Type 2 Diabetes Mellitus Blood glucose Insulin resistance Glycated hemoglobin A. |
topic |
Probióticos Diabetes Mellitus Tipo 2 Glucosa en sangre Resistencia a la insulina Hemoglobina glicosilada. Probióticos Diabetes Mellitus Tipo 2 Glicemia Resistência à insulina Hemoglobina glicada. Probiotics Type 2 Diabetes Mellitus Blood glucose Insulin resistance Glycated hemoglobin A. |
description |
The aim of this study is to summarize the evidence in the literature about the effect of probiotics on glycemic control in patients with type 2 diabetes mellitus (T2DM). This is an integrative literature review to answer the question: “What is the evidence on the use of probiotics to reduce fasting glucose and/or glycated hemoglobin and/or insulin resistance in people with T2DM”. The search was performed in the Medline-PubMed, Cochrane Library and Bireme databases using descriptors combined using the OR and AND operators. Randomized clinical trials performed with adult humans diagnosed with T2DM and which evaluated at least one of the outcomes of interest were included. The search resulted in 207 articles, of which 14 were included. The duration of the intervention ranged from 6 weeks to 6 months, the number of strains from 1 to 14, the daily dose from 106 to 1010 CFU. Most studies included Lactobacillus and Bifidobacterium. The species and strains that appeared the most were Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium lactis and Streptococcus Thermophilus. It is suggested that the use of probiotics may be a strategy for managing T2DM, as most studies have shown a positive effect on at least one of the parameters. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-03-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/27972 10.33448/rsd-v11i5.27972 |
url |
https://rsdjournal.org/index.php/rsd/article/view/27972 |
identifier_str_mv |
10.33448/rsd-v11i5.27972 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/27972/24369 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 5; e10411527972 Research, Society and Development; Vol. 11 Núm. 5; e10411527972 Research, Society and Development; v. 11 n. 5; e10411527972 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052764459630592 |